Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Impact of Intensive Outpatient Rehabilitation on Non-Motor Patient-Reported Outcomes in Parkinson's Disease (INTENSO)

Trial N/A Completed Nov. 18, 2024

A Smartphone Based, Titrated Exercise Solution for Patients With Parkinson's Disease in Daily Life: Pilot Study

Trial N/A Completed Nov. 17, 2024

Forensic Handwriting Analysis in People with Parkinson's Disease - Pilot Study

Trial N/A Completed Nov. 17, 2024

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

Trial Phase 1 Completed Nov. 11, 2024

The Relation Between the Prognosis of Subthalamic Nucleus Deep Brain Stimulation Surgery by Microlesion Effect and Electrode Position

Trial N/A Enrolling by invitation Nov. 11, 2024

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Trial Phase 1 Completed Nov. 11, 2024

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Trial N/A Recruiting Nov. 7, 2024

7.0T Magnetic Resonance Imaging Study of Parkinson's Disease

Trial N/A Recruiting Nov. 7, 2024

Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study

Trial N/A Completed Nov. 7, 2024

Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease

Trial N/A Completed Nov. 7, 2024

High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.

Trial N/A Completed Nov. 7, 2024

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Trial Phase 1 Recruiting Nov. 6, 2024

Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+

Trial N/A Suspended Nov. 5, 2024

North American Prodromal Synucleinopathy Consortium

Trial N/A Enrolling by invitation Nov. 5, 2024

Objective Assessment of Behavioural Disorders in PD

Trial N/A Active, not recruiting Nov. 5, 2024

Effects of Unblocking the Full Potential of Percept PC IPG

Trial N/A Completed Nov. 3, 2024

Quest to Analyze One Thousand Humans Meditating

Trial N/A Enrolling by invitation Oct. 31, 2024

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease

Trial Phase 1 Completed Oct. 31, 2024

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Trial Phase 1 Recruiting Oct. 31, 2024

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Trial N/A Active, not recruiting Oct. 30, 2024